Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on March 20, 2025
SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 20, 2025
– Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with Next and Final Analysis Planned Upon Reaching 80 Events, Anticipated in 2025 – – Reported Positive Overall …
Allergy Immunotherapy Market Projected To Witness Substantial Growth, 2025-2032: Aimmune Therapeutics, DBV Technologies
EIN Presswire
·
March 20, 2025
Allergy Immunotherapy Market is estimated to be valued at USD 2,740.6 Mn in 2025 and is expected to reach USD 5,276.5 Mn by 2032, exhibiting a CAGR of 9.8% BURLINGAME, CA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Latest Report, titled “ …
U.S. Intravenous Immunoglobulin Market Projected To Witness Substantial Growth, 2025-2032: Biotest AG, Octapharma AG
EIN Presswire
·
March 20, 2025
U.S. Intravenous Immunoglobulin Market is estimated to be valued at US$ 6.33 Bn in 2021, and is expected to exhibit a CAGR of 6.8% by (2021-2028). BURLINGAME, CA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Latest Report, titled “U.S. …
Healthcare Testing Services Market Projected To Witness Substantial Growth, 2025-2032: Eurofins Scientific, Pfizer Inc
EIN Presswire
·
March 20, 2025
Healthcare testing services are developed and designed in the laboratories. BURLINGAME, CA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Latest Report, titled “Healthcare Testing Services Market” Trends, Share, Size, Growth, Opportunity and …
Interventional Pulmonology Market Set to Witness Significant Growth by 2025-2032: Olympus Corporation, Vygon, Karl Storz
EIN Presswire
·
March 20, 2025
Interventional Pulmonology Market is estimated to be valued at US$ 3,535.3 million in 2021 and is expected to exhibit a CAGR of 5.4% by (2021-2028). BURLINGAME, CA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Latest Report, titled “ …
U.S. Injectable Compounding Pharmacy Market Set to Witness Significant Growth by 2025-2032: Athenex, Inc., SCA Pharma
EIN Presswire
·
March 20, 2025
U.S. Injectable Compounding Pharmacy Market is estimated to be valued at US$ 1,516.3 Mn in 2023 and is expected to exhibit a CAGR of 7.3% by (2023-2030). BURLINGAME, CA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Latest Report, titled “U.S. …
Ambulatory Infusion Center Market Set to Witness Significant Growth by 2025-2032: Walgreens Boots Alliance, Healix, LLC
EIN Presswire
·
March 20, 2025
Ambulatory Infusion Center Market is estimated to be valued USD 52.19 Bn in 2025 and is expected to reach USD 107.07 Bn by 2032, exhibiting a CAGR of 10.8%. BURLINGAME, CA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Latest Report, titled “ …
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results
GlobeNewswire
·
March 20, 2025
Fully enrolled LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients with mCRPC Initiating new LINNET Phase 2 study of lorigerlimab in ovarian cancer Advancing multiple novel topoisomerase 1 inhibitor- …
Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd.
GlobeNewswire
·
March 20, 2025
BOSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it …
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
GlobeNewswire
·
March 20, 2025
Initiated Phase 1 clinical trial evaluating its second-generation oral norovirus vaccine constructs with topline data expected as early as mid-2025 Continues per protocol follow-up for the COVID-19 Phase 2b 400-person sentinel cohort Cash, cash equivalents …
Solésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call
GlobeNewswire
·
March 20, 2025
ROMEOVILLE, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the fourth …
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
GlobeNewswire
·
March 20, 2025
Tegoprubart used as a key component of immunosuppression regimen in the second transplant of a genetically modified pig kidney into a human conducted at Massachusetts General Hospital Announced positive initial data from first three subjects with type 1 …
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025
GlobeNewswire
·
March 20, 2025
NEWTON, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the …
Spectral AI Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Spectral IP
GlobeNewswire
·
March 20, 2025
DALLAS, March 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration in 2018 and uses …
Take the Lead: Forward a New Evolution in Slide-Free Pathology with MUSE Microscopy’s Groundbreaking SmartPath Technology
GlobeNewswire
·
March 20, 2025
IRVINE, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a pioneer in digital pathology innovation, is proud to announce the development of its revolutionary slide-free, digital tissue imaging platform. This cutting-edge technology is set …
Phenylketonuria Treatment Market Set to Surge at 7.8% CAGR, to Reach US$ 1.62 Billion by 2034: Fact.MR Report
EIN Presswire
·
March 20, 2025
Awareness Campaigns by Governments and Regulatory Bodies Regarding Phenylketonuria Treatment Playing Key Role in Market Expansion: Fact.MR Report ROCKVILLE, MD, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- According to a recently updated industry …
Geared Power Secures USPTO Allowance for BioGuard UVC™, New Advance in the Fight Against Antimicrobial Resistance & HAIs
EIN Presswire
·
March 20, 2025
Nominated in 'The Coolest Thing Made in NJ' contest WAYNE, NJ, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Geared Power, a rising star in HealthTech innovation, today announced that its groundbreaking BioGuard UVC™ device has received a Letter …
Teclison, Inc. to Participate in Upcoming Investor Conference
GlobeNewswire
·
March 20, 2025
PRINCETON, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- Teclison, Inc., a clinical-stage oncology company dedicated to advancing immunotherapeutic treatments for solid tumors, today announced that Ray Lee, chief executive officer and co-founder of Teclison …
The Hidden Truth About Ice Dispensers: Industry Trends and Innovations
EIN Presswire
·
March 20, 2025
"Ice Dispensers 2025: The Future of Ice and How It Impacts Your Business! DALLAS, TX, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- The commercial ice dispenser market is experiencing substantial growth, driven by increasing demand in sectors such …
CURE Media Group and Oncology Nursing News® announce the 2025 Extraordinary Healer® award finalists and keynote speaker, Amy Robach
GlobeNewswire
·
March 20, 2025
CRANBURY, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- CURE Media Group and Oncology Nursing News® are pleased to announce the finalists for the 2025 Extraordinary Healer® award. This award honors oncology nurses whose compassion and expertise improve the …